France digital PCR (DPCR) and real-time PCR (QPCR) Market Size, Growth, Industry Trends, Market Share and Forecast 2019-2025

France digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.8% during the forecast period. France is one of the leading France biotech eco-systems along with Germany and UK. The increasing R&D in the life sciences sector is one of the major factors that is driving the growth of the market of dPCR and qPCR in the country. The other factors that are driving the growth of the dPCR and qPCR market include the extensive R&D in gene therapy techniques, infectious medicine, and the treatment of diseases such as cancer, metabolic diseases, and CVD.

Request a Free Sample of our Report on France digital PCR (DPCR) and real-time PCR (QPCR) Market: https://www.omrglobal.com/request-sample/france-digital-pcr-and-real-time-pcr-market

Along with this, as the dPCR and qPCR has a significant application in cell and gene therapy development, the market for dPCR and qPCR in France is expected to hold a considerable share in the global market. France has a strong pharmaceutical industry with 32 biomanufacturing sites generating more than 19% revenue in pharmaceutical production and 8.6% of total employment in the sector. Within the country, there is a heavy concentration of biomanufacturing sites in the Rh�ne-Alpes region and the Paris Basin.

The companies operating in the country include bioM�rieux S.A., Stilla Technologies, Qiagen N.V., Analytik Jena AG, Thermo Fisher Scientific Inc., and Eppendorf AG. bioM�rieux S.A. offers several technologies and systems such as include automated VITEK 2 system and Etest for identifying bacteria and analyzing their susceptibility to antibiotics. It also includes a mass spectrometry-based system, VITEK MS for the identification of fungi, bacteria, and mycobacteria.

The company also offers immunoassays products such as VIDAS, bioNexia and VIKIA range of products for rapid tests. Moreover, the company provides molecular biology products such as NucliSENS easyMAG and NucliSENS miniMAG, and ARGENE and NucliSENS EasyQ. For instance, in November 2018, the company got the US FDA approval for BIOFIRE FILMARRAY Pneumonia Panel and the CE-Mark of the BIOFIRE FILMARRAY Pneumonia Panel plus. The BIOFIRE FILMARRAY has used real-time PCR quantification capabilities for the first time in semi-quantitative levels for 15 bacteria which may aid clinicians to differentiate colonization from true invasive infection.

A Full Report of France digital PCR (DPCR) and real-time PCR (QPCR) Market is Available at https://www.omrglobal.com/industry-reports/france-digital-pcr-and-real-time-pcr-market

France dPCR and qPCR Market by Technology
o Quantitative PCR (qPCR)
o Digital PCR (dPCR)

France dPCR and qPCR Market by Product
o Reagents and Consumables
o Instruments
o Software

France dPCR and qPCR Market by Application
o Research Application
o Clinical Application
o Forensic Application

Company Profiles
o Analytik Jena AG
o bioM�rieux S.A.
o Bio-Rad Laboratories, Inc.
o Eppendorf AG
o Merck KGaA
o Qiagen N.V.
o Siemens AG
o Stilla Technologies
o Thermo Fisher Scientific Inc.
o Promega Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/france-digital-pcr-and-real-time-pcr-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.